Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Weaver

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
Journal of the American College of Cardiology|September 1, 1991
Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project GroupW D Weaver, P E Litwin, J S Martin, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Journal of the American College of Cardiology|April 1, 1990
Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapyW D Weaver, M S Eisenberg, J S Martin, et al.
Annals of Internal Medicine|July 1, 1984
Ventricular fibrillation causes sudden death in Southeast Asian immigrantsC M Otto, R V Tauxe, L A Cobb, et al.
Circulation|November 15, 1995
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary ArteriesJ M Gore, C B Granger, M L Simoons, et al.
Journal of the American College of Cardiology|March 1, 1996
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyD J Kereiakes, N S Kleiman, J Ambrose, et al.
Journal of the American College of Cardiology|March 1, 1996
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trialL K Newby, R M Califf, A Guerci, et al.
American Heart Journal|June 1, 1997
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I InvestigatorsR M Califf, L H Woodlief, F E Harrell, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
Journal of the American College of Cardiology|September 1, 1991
Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project GroupW D Weaver, P E Litwin, J S Martin, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Journal of the American College of Cardiology|April 1, 1990
Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapyW D Weaver, M S Eisenberg, J S Martin, et al.
Annals of Internal Medicine|July 1, 1984
Ventricular fibrillation causes sudden death in Southeast Asian immigrantsC M Otto, R V Tauxe, L A Cobb, et al.
Circulation|November 15, 1995
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary ArteriesJ M Gore, C B Granger, M L Simoons, et al.
Journal of the American College of Cardiology|March 1, 1996
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyD J Kereiakes, N S Kleiman, J Ambrose, et al.
Journal of the American College of Cardiology|March 1, 1996
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trialL K Newby, R M Califf, A Guerci, et al.
American Heart Journal|June 1, 1997
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I InvestigatorsR M Califf, L H Woodlief, F E Harrell, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
Pageof 17